Literature DB >> 2320231

Motor neuron disease and amyotrophic lateral sclerosis: relation of high CSF protein content to paraproteinemia and clinical syndromes.

D S Younger1, L P Rowland, N Latov, W Sherman, M Pesce, D J Lange, W Trojaborg, J R Miller, R E Lovelace, A P Hays.   

Abstract

From 1984 to 1988, 11 of 120 patients (9%) with motor neuron disease (MND) had paraproteins detected by serum immunofixation electrophoresis (IFE), compared with 4 (3%) by cellulose acetate gels: 1 patient had progressive spinal muscular atrophy, 5 patients had amyotrophic lateral sclerosis (ALS), and 5 patients had ALS with probable upper motor neuron signs. Four of 5 patients (80%) with cerebrospinal fluid (CSF) protein content above 75 mg/dl had paraproteins, as did 6 of 30 with values above 50 mg/dl. Four of 14 patients with cerebrospinal oligoclonal bands (OCB) also had paraproteins. Two patients with ALS, CSF protein content above 75 mg/dl, and paraproteinemia had lymphoma. We conclude the following about patients with MND: high CSF protein content (especially above 75 mg/dl) or CSF OCB makes paraproteinemia more likely; some of these patients may have lymphoma; there is an inordinately high occurrence of paraproteinemia in MND; and IFE on agarose is more sensitive than electrophoresis on cellulose acetate in detecting paraproteins. Syndromes of paraproteinemia and high CSF protein are not restricted to the lower motor neuron but qualify as "ALS" with coexisting upper motor neuron signs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2320231     DOI: 10.1212/wnl.40.4.595

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  12 in total

1.  Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950.

Authors:  A M Chancellor; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

2.  SOD1 in cerebral spinal fluid as a pharmacodynamic marker for antisense oligonucleotide therapy.

Authors:  Leah Winer; Dushyanth Srinivasan; Seung Chun; David Lacomis; Matthew Jaffa; Anne Fagan; David M Holtzman; Ed Wancewicz; C Frank Bennett; Robert Bowser; Merit Cudkowicz; Timothy M Miller
Journal:  JAMA Neurol       Date:  2013-02       Impact factor: 18.302

3.  Concomitant amyotrophic lateral sclerosis and paraclinical laboratory features of multiple sclerosis: coincidence or causal relationship?

Authors:  Nadja Borisow; Thomas Meyer; Friedemann Paul
Journal:  BMJ Case Rep       Date:  2013-01-23

Review 4.  Atypical motor neuron disease with severe ophthalmoloplegia: a report of two cases.

Authors:  N Yuki; M Yamada; T Yuasa; K Kaneko; T Inuzuka; M Arai; S Sato; S Tsuji; S Takeda; K Kawasaki
Journal:  J Neurol       Date:  1995-08       Impact factor: 4.849

5.  Primary lateral sclerosis: clinical, neurophysiological, and magnetic resonance findings.

Authors:  J Kuipers-Upmeijer; A E de Jager; J M Hew; J W Snoek; T W van Weerden
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-11       Impact factor: 10.154

6.  Inflammatory cells in the peripheral nervous system in motor neuron disease.

Authors:  H Kerkhoff; D Troost; E S Louwerse; M van Dijk; H Veldman; F G Jennekens
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

7.  A characteristic ganglioside antibody pattern in the CSF of patients with amyotrophic lateral sclerosis.

Authors:  A Stevens; M Weller; H Wiethölter
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-04       Impact factor: 10.154

8.  Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients.

Authors:  John P Bida; Robert A Kyle; Terry M Therneau; L Joseph Melton; Matthew F Plevak; Dirk R Larson; Angela Dispenzieri; Jerry A Katzmann; S Vincent Rajkumar
Journal:  Mayo Clin Proc       Date:  2009-08       Impact factor: 7.616

9.  Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue.

Authors:  T Kawamata; H Akiyama; T Yamada; P L McGeer
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

10.  Specific electron transport chain abnormalities in amyotrophic lateral sclerosis.

Authors:  Jerry Lin; Andrew Diamanduros; Soheli A Chowdhury; Stephen Scelsa; Norman Latov; Saud A Sadiq
Journal:  J Neurol       Date:  2009-02-25       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.